APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Treatment for Mental Health

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Treatment for Mental Health Market Analysis and Forecast 2026-2032

Report ID 17404293022 January 2026192 pages

Choose your research edition.

Industry ResearchTreatment for Mental Health Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Treatment for Mental Health Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Treatment for Mental Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Treatment for Mental Health Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Treatment for Mental Health Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Treatment for Mental Health market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Treatment for Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Treatment for Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Treatment for Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Treatment for Mental Health is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Treatment for Mental Health include Takeda, Johnson & Johnson, Eli Lilly, Pfizer and Shionogi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Treatment for Mental Health, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Treatment for Mental Health, also provides the revenue of main regions and countries. Of the upcoming market potential for Treatment for Mental Health, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Treatment for Mental Health revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Treatment for Mental Health market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Treatment for Mental Health revenue, projected growth trends, production technology, application and end-user industry.

Treatment for Mental Health Segment by Company

Takeda

Johnson & Johnson

Eli Lilly

Pfizer

Shionogi

Treatment for Mental Health Segment by Type

Teenager

Adult

Treatment for Mental Health Segment by Application

Hospital

Clinic

Others

Treatment for Mental Health Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment for Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Treatment for Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment for Mental Health.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Treatment for Mental Health in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Treatment for Mental Health company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Treatment for Mental Health revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Treatment for Mental Health Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Teenager Major Player Table 3. Adult Major Player Table 4. Global Treatment for Mental Health Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Others Major Player Table 8. Treatment for Mental Health Industry Trends Table 9. Treatment for Mental Health Industry Drivers Table 10. Treatment for Mental Health Industry Opportunities and Challenges Table 11. Treatment for Mental Health Industry Restraints Table 12. Global Treatment for Mental Health Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Treatment for Mental Health Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Treatment for Mental Health Market Share by Region (2021-2026) Table 15. Global Treatment for Mental Health Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Treatment for Mental Health Market Share by Region (2027-2032) Table 17. Global Treatment for Mental Health Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Treatment for Mental Health Revenue Market Share by Players (2021-2026) Table 19. Global Treatment for Mental Health Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Treatment for Mental Health Key Players Headquarters & Area Served Table 21. Global Treatment for Mental Health Players, Product Type & Application Table 22. Global Treatment for Mental Health Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Treatment for Mental Health by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Treatment for Mental Health Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Treatment for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Treatment for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Treatment for Mental Health Revenue Market Share by Type (2021-2026) Table 29. Global Treatment for Mental Health Revenue Market Share by Type (2027-2032) Table 30. Global Treatment for Mental Health Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Treatment for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Treatment for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Treatment for Mental Health Revenue Market Share by Application (2021-2026) Table 34. Global Treatment for Mental Health Revenue Market Share by Application (2027-2032) Table 35. Takeda Company Information Table 36. Takeda Business Overview Table 37. Takeda Treatment for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Treatment for Mental Health Product Portfolio Table 39. Takeda Recent Development Table 40. Johnson & Johnson Company Information Table 41. Johnson & Johnson Business Overview Table 42. Johnson & Johnson Treatment for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Johnson & Johnson Treatment for Mental Health Product Portfolio Table 44. Johnson & Johnson Recent Development Table 45. Eli Lilly Company Information Table 46. Eli Lilly Business Overview Table 47. Eli Lilly Treatment for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Eli Lilly Treatment for Mental Health Product Portfolio Table 49. Eli Lilly Recent Development Table 50. Pfizer Company Information Table 51. Pfizer Business Overview Table 52. Pfizer Treatment for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pfizer Treatment for Mental Health Product Portfolio Table 54. Pfizer Recent Development Table 55. Shionogi Company Information Table 56. Shionogi Business Overview Table 57. Shionogi Treatment for Mental Health Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Shionogi Treatment for Mental Health Product Portfolio Table 59. Shionogi Recent Development Table 60. North America Treatment for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 61. North America Treatment for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 62. North America Treatment for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 63. North America Treatment for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 64. North America Treatment for Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 65. North America Treatment for Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 66. North America Treatment for Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 67. Europe Treatment for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 68. Europe Treatment for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 69. Europe Treatment for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 70. Europe Treatment for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 71. Europe Treatment for Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Europe Treatment for Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 73. Europe Treatment for Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 74. China Treatment for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 75. China Treatment for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 76. China Treatment for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 77. China Treatment for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 78. Asia Treatment for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 79. Asia Treatment for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 80. Asia Treatment for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 81. Asia Treatment for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 82. Asia Treatment for Mental Health Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 83. Asia Treatment for Mental Health Revenue by Region (US$ Million) & (2021-2026) Table 84. Asia Treatment for Mental Health Revenue by Region (US$ Million) & (2027-2032) Table 85. SAMEA Treatment for Mental Health Revenue by Type (2021-2026) & (US$ Million) Table 86. SAMEA Treatment for Mental Health Revenue by Type (2027-2032) & (US$ Million) Table 87. SAMEA Treatment for Mental Health Revenue by Application (2021-2026) & (US$ Million) Table 88. SAMEA Treatment for Mental Health Revenue by Application (2027-2032) & (US$ Million) Table 89. SAMEA Treatment for Mental Health Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. SAMEA Treatment for Mental Health Revenue by Country (2021-2026) & (US$ Million) Table 91. SAMEA Treatment for Mental Health Revenue by Country (US$ Million) & (2027-2032) Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Treatment for Mental Health Image Figure 2. Global Treatment for Mental Health Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Treatment for Mental Health Market Size Share 2021 VS 2025 VS 2032 Figure 4. Teenager Image Figure 5. Adult Image Figure 6. Global Treatment for Mental Health Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Treatment for Mental Health Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Treatment for Mental Health Market Size (US$ Million) & (2021-2032) Figure 12. Global Treatment for Mental Health Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Treatment for Mental Health Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Treatment for Mental Health Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Treatment for Mental Health Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Treatment for Mental Health Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Treatment for Mental Health Revenue Market Share by Type (2021-2032) Figure 19. Global Treatment for Mental Health Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Treatment for Mental Health Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Treatment for Mental Health Revenue Market Share by Application (2021-2032) Figure 22. North America Treatment for Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Treatment for Mental Health Revenue Share by Type (2021-2032) Figure 24. North America Treatment for Mental Health Revenue Share by Application (2021-2032) Figure 25. North America Treatment for Mental Health Revenue Share by Country (2021-2032) Figure 26. United States Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Treatment for Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Treatment for Mental Health Revenue Share by Type (2021-2032) Figure 31. Europe Treatment for Mental Health Revenue Share by Application (2021-2032) Figure 32. Europe Treatment for Mental Health Revenue Share by Country (2021-2032) Figure 33. Germany Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Treatment for Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Treatment for Mental Health Revenue Share by Type (2021-2032) Figure 43. China Treatment for Mental Health Revenue Share by Application (2021-2032) Figure 44. Asia Treatment for Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Treatment for Mental Health Revenue Share by Type (2021-2032) Figure 46. Asia Treatment for Mental Health Revenue Share by Application (2021-2032) Figure 47. Asia Treatment for Mental Health Revenue Share by Region (2021-2032) Figure 48. Japan Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Treatment for Mental Health Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Treatment for Mental Health Revenue Share by Type (2021-2032) Figure 56. SAMEA Treatment for Mental Health Revenue Share by Application (2021-2032) Figure 57. SAMEA Treatment for Mental Health Revenue Share by Country (2021-2032) Figure 58. Brazil Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Treatment for Mental Health Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Teenager
  • Adult
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Takeda
  • Johnson & Johnson
  • Eli Lilly
  • Pfizer
  • Shionogi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Treatment for Mental Health Market by Type
  3. 1.2.1 Global Treatment for Mental Health Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Teenager
  5. 1.2.3 Adult
  6. 1.3 Treatment for Mental Health Market by Application
  7. 1.3.1 Global Treatment for Mental Health Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Treatment for Mental Health Market Dynamics
  1. 2.1 Treatment for Mental Health Industry Trends
  2. 2.2 Treatment for Mental Health Industry Drivers
  3. 2.3 Treatment for Mental Health Industry Opportunities and Challenges
  4. 2.4 Treatment for Mental Health Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Treatment for Mental Health Market Perspective (2021-2032)
  2. 3.2 Global Treatment for Mental Health Growth Trends by Region
  3. 3.2.1 Global Treatment for Mental Health Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Treatment for Mental Health Market Size by Region (2021-2026)
  5. 3.2.3 Global Treatment for Mental Health Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Treatment for Mental Health Revenue by Players
  2. 4.1.1 Global Treatment for Mental Health Revenue by Players (2021-2026)
  3. 4.1.2 Global Treatment for Mental Health Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Treatment for Mental Health Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Treatment for Mental Health Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Treatment for Mental Health Key Players Headquarters & Area Served
  7. 4.4 Global Treatment for Mental Health Players, Product Type & Application
  8. 4.5 Global Treatment for Mental Health Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Treatment for Mental Health Market CR5 and HHI
  11. 4.6.3 2025 Treatment for Mental Health Tier 1, Tier 2, and Tier 3
5 Treatment for Mental Health Market Size by Type
  1. 5.1 Global Treatment for Mental Health Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Treatment for Mental Health Revenue by Type (2021-2032)
  3. 5.3 Global Treatment for Mental Health Revenue Market Share by Type (2021-2032)
6 Treatment for Mental Health Market Size by Application
  1. 6.1 Global Treatment for Mental Health Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Treatment for Mental Health Revenue by Application (2021-2032)
  3. 6.3 Global Treatment for Mental Health Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Treatment for Mental Health Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Treatment for Mental Health Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Treatment for Mental Health Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Treatment for Mental Health Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Treatment for Mental Health Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Treatment for Mental Health Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Treatment for Mental Health Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Treatment for Mental Health Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 Shionogi
  26. 7.5.1 Shionogi Company Information
  27. 7.5.2 Shionogi Business Overview
  28. 7.5.3 Shionogi Treatment for Mental Health Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Shionogi Treatment for Mental Health Product Portfolio
  30. 7.5.5 Shionogi Recent Developments
8 North America
  1. 8.1 North America Treatment for Mental Health Revenue (2021-2032)
  2. 8.2 North America Treatment for Mental Health Revenue by Type (2021-2032)
  3. 8.2.1 North America Treatment for Mental Health Revenue by Type (2021-2026)
  4. 8.2.2 North America Treatment for Mental Health Revenue by Type (2027-2032)
  5. 8.3 North America Treatment for Mental Health Revenue Share by Type (2021-2032)
  6. 8.4 North America Treatment for Mental Health Revenue by Application (2021-2032)
  7. 8.4.1 North America Treatment for Mental Health Revenue by Application (2021-2026)
  8. 8.4.2 North America Treatment for Mental Health Revenue by Application (2027-2032)
  9. 8.5 North America Treatment for Mental Health Revenue Share by Application (2021-2032)
  10. 8.6 North America Treatment for Mental Health Revenue by Country
  11. 8.6.1 North America Treatment for Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Treatment for Mental Health Revenue by Country (2021-2026)
  13. 8.6.3 North America Treatment for Mental Health Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Treatment for Mental Health Revenue (2021-2032)
  2. 9.2 Europe Treatment for Mental Health Revenue by Type (2021-2032)
  3. 9.2.1 Europe Treatment for Mental Health Revenue by Type (2021-2026)
  4. 9.2.2 Europe Treatment for Mental Health Revenue by Type (2027-2032)
  5. 9.3 Europe Treatment for Mental Health Revenue Share by Type (2021-2032)
  6. 9.4 Europe Treatment for Mental Health Revenue by Application (2021-2032)
  7. 9.4.1 Europe Treatment for Mental Health Revenue by Application (2021-2026)
  8. 9.4.2 Europe Treatment for Mental Health Revenue by Application (2027-2032)
  9. 9.5 Europe Treatment for Mental Health Revenue Share by Application (2021-2032)
  10. 9.6 Europe Treatment for Mental Health Revenue by Country
  11. 9.6.1 Europe Treatment for Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Treatment for Mental Health Revenue by Country (2021-2026)
  13. 9.6.3 Europe Treatment for Mental Health Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Treatment for Mental Health Revenue (2021-2032)
  2. 10.2 China Treatment for Mental Health Revenue by Type (2021-2032)
  3. 10.2.1 China Treatment for Mental Health Revenue by Type (2021-2026)
  4. 10.2.2 China Treatment for Mental Health Revenue by Type (2027-2032)
  5. 10.3 China Treatment for Mental Health Revenue Share by Type (2021-2032)
  6. 10.4 China Treatment for Mental Health Revenue by Application (2021-2032)
  7. 10.4.1 China Treatment for Mental Health Revenue by Application (2021-2026)
  8. 10.4.2 China Treatment for Mental Health Revenue by Application (2027-2032)
  9. 10.5 China Treatment for Mental Health Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Treatment for Mental Health Revenue (2021-2032)
  2. 11.2 Asia Treatment for Mental Health Revenue by Type (2021-2032)
  3. 11.2.1 Asia Treatment for Mental Health Revenue by Type (2021-2026)
  4. 11.2.2 Asia Treatment for Mental Health Revenue by Type (2027-2032)
  5. 11.3 Asia Treatment for Mental Health Revenue Share by Type (2021-2032)
  6. 11.4 Asia Treatment for Mental Health Revenue by Application (2021-2032)
  7. 11.4.1 Asia Treatment for Mental Health Revenue by Application (2021-2026)
  8. 11.4.2 Asia Treatment for Mental Health Revenue by Application (2027-2032)
  9. 11.5 Asia Treatment for Mental Health Revenue Share by Application (2021-2032)
  10. 11.6 Asia Treatment for Mental Health Revenue by Country
  11. 11.6.1 Asia Treatment for Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Treatment for Mental Health Revenue by Country (2021-2026)
  13. 11.6.3 Asia Treatment for Mental Health Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Treatment for Mental Health Revenue (2021-2032)
  2. 12.2 SAMEA Treatment for Mental Health Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Treatment for Mental Health Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Treatment for Mental Health Revenue by Type (2027-2032)
  5. 12.3 SAMEA Treatment for Mental Health Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Treatment for Mental Health Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Treatment for Mental Health Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Treatment for Mental Health Revenue by Application (2027-2032)
  9. 12.5 SAMEA Treatment for Mental Health Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Treatment for Mental Health Revenue by Country
  11. 12.6.1 SAMEA Treatment for Mental Health Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Treatment for Mental Health Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Treatment for Mental Health Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst